Loading patent…
AssigneeThe General Hospital Corporation
InventorsBrian Seed, Babak Banapour, Charles Romeo, Waldemar Kolanus
Estimating the term…
Disclosed is a method of directing a cellular immune response against an HIV-infected cell in a mammal involving administering to the mammal an effective amount of therapeutic cells which express a membrane-bound, proteinaceous chimeric receptor comprising (a) an extracellular portion which includes a fragment of CD4 which is capable of specifically recognizing and binding the HIV-infected cell but which does not mediate HIV infection and (b) an intracellular portion which is capable of signalling the therapeutic cell to destroy the receptor-bound HIV-infected cell. Also disclosed are cells which express the chimeric receptors and DNA and vectors encoding the chimeric receptors.
A method of directing a cellular immune response against HIV or an HIV-infected cell in a mammal, said method comprising administering to said mammal an effective amount of therapeutic cells, said therapeutic cells expressing a membrane-bound, proteinaceous chimeric receptor comprising (a) an extracellular portion which includes a fragment of CD4 which specifically recognizes and binds said HIV or said HIV-infected cell but which does not mediate HIV infection, (b) a transmembrane portion, and (c) an intracellular portion which signals said therapeutic cell to destroy said receptor-bound HIV or said HIV-infected cell.
Dependencies are inferred from the claim text.